Diagnostic Performance of 68Ga-PSMA-11 PET/CT Compared with Multiparametric MRI for Initial Local Staging of Prostate Cancer
Cancers · 19.11.2026 · 18 (22) · 3697
DOI: 10.3390/cancers18223697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.11.2026. Verfasst von Seong Hyeon Yu und 11 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) remains insufficient for the initial local staging of prostate cancer (PC). This study aimed to compare the diagnostic accuracy of 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging (mpMRI) for localised or locally advanced PC.
Methods
We retrospectively reviewed patients who underwent preoperative 68Ga-PSMA-11 PET/CT and prostate mpMRI followed by radical prostatectomy (RP) at two tertiary institutions between August 2022 and April 2026. Side-specific PC, extraprostatic extension (EPE) and seminal vesicle invasion (SVI) were assessed using two imaging modalities and compared to pathologic T staging via RP. The diagnostic performance of 68Ga-PSMA-11 PET/CT and mpMRI was investigated.
Results
Overall, 440 patients were included. Regarding side-specific PC detection, 68Ga-PSMA-11 PET/CT showed significantly higher sensitivity than mpMRI (72.9% vs. 61.8%, p < 0.001), whereas mpMRI had higher specificity (93.3% vs. 76.7%, p = 0.009). The two modalities showed similar overall discrimination (area under the receiver operating characteristic curve [AUC], 0.748 vs. 0.776, p = 0.323). For EPE, mpMRI had higher sensitivity than 68Ga-PSMA-11 PET/CT (42.3% vs. 7.1%, p < 0.001), whereas 68Ga-PSMA-11 PET/CT had higher specificity (96.1% vs. 84.5%, p < 0.001). Overall performance favoured mpMRI (AUCs, 0.634 vs. 0.516; p < 0.001). For SVI, mpMRI outperformed 68Ga-PSMA-11 PET/CT in sensitivity (48.7% vs. 20.5%, p = 0.002) and overall discrimination (AUC, 0.730 vs. 0.598; p = 0.001), while specificity was comparable (97.3% vs. 99.0%, p = 0.052).
Conclusions
68Ga-PSMA-11 PET/CT shows promise for the initial local staging of PC. The higher sensitivity of 68Ga-PSMA-11 PET/CT for localised PC suggests a potential complementary role in surgical planning. Conversely, in patients with EPE or SVI, mpMRI provides superior diagnostic performance overall.
Zitieren
APA
Yu, S. H., Cho, S., Gu, H. M., Chung, H. S., Hwang, E. C., Jung, S. I., Kang, T. W., Kwon, D., Moon, J. B., Kim, N. I., Kim, S. S., & Heo, S. H. (2026). Diagnostic Performance of 68Ga-PSMA-11 PET/CT Compared with Multiparametric MRI for Initial Local Staging of Prostate Cancer. Cancers, 18(22), 3697. https://doi.org/10.3390/cancers18223697
Vancouver
Yu SH, Cho S, Gu HM, Chung HS, Hwang EC, Jung SI, et al. Diagnostic Performance of 68Ga-PSMA-11 PET/CT Compared with Multiparametric MRI for Initial Local Staging of Prostate Cancer. Cancers. 2026;18(22):3697. doi:10.3390/cancers18223697
BibTeX
@article{Yu2026,
author = {Yu, Seong Hyeon and Cho, Sang-Geon and Gu, Hui Mo and Chung, Ho Seok and Hwang, Eu Chang and Jung, Seung Il and Kang, Taek Won and Kwon, Dongdeuk and Moon, Jang Bae and Kim, Nah Ihm and Kim, Sung Sun and Heo, Suk Hee},
title = {Diagnostic Performance of 68Ga-PSMA-11 PET/CT Compared with Multiparametric MRI for Initial Local Staging of Prostate Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3697},
doi = {10.3390/cancers18223697}
}
EUVIMED